Alzheimer’s disease (AD) induces profound circadian disruption—characterized by suprachiasmatic nucleus (SCN) degeneration, Aβ and tau pathology, and aberrant melatonin secretion which results in fragmented sleep–wake cycles and cognitive decline. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.